Please confirm you are human

This browser or connection looks automated. Press and continuously hold the control for 3 seconds to enable Google-hosted web results and, when separately allowed, AI-assisted answers.

A successful check enables 100 search requests. Interactive access does not authorize scraping, systematic collection, or reuse of search output.

Hold with a pointer, or hold Space or Enter.

News

Hematology Advisor
hematologyadvisor.com > news > treatable-maternal-anemia-mca-psv-elevated-treatment-risk

Treatable Maternal Anemia Is a Potential Cause of Elevated Fetal MCA-PSV

1+ week, 6+ day ago   (319+ words) Extremely low maternal hemoglobin levels may generate the development of fetal hypoxemia and fetal hemodynamic changes, thus warranting consideration in the diagnostic evaluation of unexplained elevated middle cerebral artery peak systolic velocity (MCA-PSV), even in cases of hemolytic disease of…...

Hematology Advisor
hematologyadvisor.com > news > maternal-thrombocytopenia-better-outcomes-risk-adapted-pathways

Risk-Adapted Pathways for Maternal Thrombocytopenia Can Lead to Better Outcomes

1+ mon, 3+ day ago   (488+ words) Real-world data from a retrospective, 18-month cohort study of women with thrombocytopenia referred to the obstetric hematology service support using risk-adapted pathways to optimize resource utilization while also ensuring maternal and neonatal outcomes are safeguarded. Researchers delineated the etiologic spectrum…...

Hematology Advisor
hematologyadvisor.com > news > fnait-thrombocytopenia-management-future-pregnancies-calls-strategy

For FNAIT, Management in Future Pregnancies Calls for Risk-Based Strategy

1+ mon, 3+ day ago   (394+ words) Among women who have experienced a previous pregnancy affected by fetal and neonatal alloimmune thrombocytopenia (FNAIT), there is a nearly 100% risk for recurrence of the disorder in a subsequent pregnancy, according to findings from a case study described recently in…...